Matthew Hotchko, PhD
For well over a year, pharmacists, physicians and patients have been dealing with sporadic shortages of immune globulin (IG) products, as the COVID-19 pandemic led to a significant decline in donations of the blood plasma that is the primary component of these therapies.
According to the Plasma Protein Therapeutics Association (PPTA), plasma donations fell by 20% in 2020. Because the fractionation process that turns donated plasma into IG can take nine to 12